{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:23:30Z","timestamp":1777382610224,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40121-023-00865-3","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:02:03Z","timestamp":1694628123000},"page":"2259-2268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Misoprostol-Induced Fever and Unnecessary Antibiotic Prescribing: A Retrospective Study"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-1485","authenticated-orcid":false,"given":"Laila Carolina","family":"Abu Esba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Al Mardawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Al Mardawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay Musaed","family":"Almadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam I.","family":"Ardah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"4","key":"865_CR1","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1016\/s0960-9822(99)80085-2","volume":"9","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA, Gatti S, Bartfai T. Fever: links with an ancient receptor. Curr Biol. 1999;9(4):R147\u201350. https:\/\/doi.org\/10.1016\/s0960-9822(99)80085-2. (PMID: 10074418).","journal-title":"Curr Biol"},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(09)61923-1","volume":"375","author":"J Blum","year":"2010","unstructured":"Blum J, Winikoff B, Raghavan S, et\u00a0al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375:217\u201323.","journal-title":"Lancet"},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0140-6736(09)61924-3","volume":"375","author":"B Winikoff","year":"2010","unstructured":"Winikoff B, Dabash R, Durocher J, et\u00a0al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet. 2010;375:210\u20136.","journal-title":"Lancet"},{"issue":"7","key":"865_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","volume":"117","author":"J Durocher","year":"2010","unstructured":"Durocher J, Bynum J, Le\u00f3n W, Barrera G, Winikoff B. High fever following postpartum administration of sublingual misoprostol. BJOG. 2010;117(7):845\u201352. https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02564.x.","journal-title":"BJOG"},{"issue":"6","key":"865_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/tmi.13389","volume":"25","author":"J Durocher","year":"2020","unstructured":"Durocher J, Aguirre JD, Dzuba IG, et\u00a0al. High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in Argentina. Trop Med Int Health. 2020;25(6):714\u201322. https:\/\/doi.org\/10.1111\/tmi.13389.","journal-title":"Trop Med Int Health"},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2393-12-65","volume":"12","author":"W Le\u00f3n","year":"2012","unstructured":"Le\u00f3n W, Durocher J, Barrera G, Pinto E, Winikoff B. Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make? BMC Pregnancy Childbirth. 2012;12:65. https:\/\/doi.org\/10.1186\/1471-2393-12-65.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"865_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/aog.0b013e3182707341","volume":"120","author":"A Elati","year":"2012","unstructured":"Elati A, Weeks A. Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis. Obstet Gynecol. 2012;120(5):1140\u20138. https:\/\/doi.org\/10.1097\/aog.0b013e3182707341.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"865_CR8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2217\/pgs.15.53","volume":"16","author":"A Alfirevic","year":"2015","unstructured":"Alfirevic A, Durocher J, Elati A, et\u00a0al. Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry. Pharmacogenomics. 2015;16(9):919\u201328. https:\/\/doi.org\/10.2217\/pgs.15.53.","journal-title":"Pharmacogenomics"},{"key":"865_CR9","doi-asserted-by":"publisher","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology, Society of Family Planning. Medication abortion up to 70 days of gestation: ACOG practice bulletin, number 225. Obstet Gynecol. 2020;136(4):e31\u2013e47. https:\/\/doi.org\/10.1097\/AOG.0000000000004082. (PMID: 32804884).","DOI":"10.1097\/AOG.0000000000004082"},{"issue":"3","key":"865_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ijgo.12181","volume":"138","author":"JL Morris","year":"2017","unstructured":"Morris JL, Winikoff B, Dabash R, Weeks A, Faundes A, Gemzell-Danielsson K, Kapp N, Castleman L, Kim C, Ho PC, Visser GHA. FIGO\u2019s updated recommendations for misoprostol used alone in gynecology and obstetrics. Int J Gynaecol Obstet. 2017;138(3):363\u20136. https:\/\/doi.org\/10.1002\/ijgo.12181. (Epub 2017 Jun 23 PMID: 28643396).","journal-title":"Int J Gynaecol Obstet"},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6939-15-10","volume":"15","author":"A Al-Matary","year":"2014","unstructured":"Al-Matary A, Ali J. Controversies and considerations regarding the termination of pregnancy for foetal anomalies in Islam. BMC Med Ethics. 2014;15:10. https:\/\/doi.org\/10.1186\/1472-6939-15-10.","journal-title":"BMC Med Ethics"},{"issue":"12","key":"865_CR12","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/cid\/ciw658","volume":"63","author":"ES Spivak","year":"2016","unstructured":"Spivak ES, Cosgrove SE, Srinivasan A. Measuring appropriate antimicrobial use: attempts at opening the black box. Clin Inf Dis. 2016;63(12):1639\u201344. https:\/\/doi.org\/10.1093\/cid\/ciw658.","journal-title":"Clin Inf Dis"},{"issue":"2","key":"865_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jcpt.13306","volume":"46","author":"LC Abu Esba","year":"2021","unstructured":"Abu Esba LC, Al Mardawi G, Al Jasser MI, Aljohani B, Abu Alburak A. Adverse drug reactions spontaneously reported at a tertiary care hospital and preventable measures implemented. J Clin Pharm Ther. 2021;46(2):460\u20139. https:\/\/doi.org\/10.1111\/jcpt.13306. (Epub 2020 Dec 7. PMID: 33285001; PMCID: PMC8247361).","journal-title":"J Clin Pharm Ther."},{"issue":"3","key":"865_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.contraception.2009.03.010","volume":"80","author":"M Fjerstad","year":"2009","unstructured":"Fjerstad M, Sivin I, Lichtenberg ES, Trussell J, Cleland K, Cullins V. Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception. 2009;80(3):282\u20136. https:\/\/doi.org\/10.1016\/j.contraception.2009.03.010. (Epub 2009 May 2. PMID: 19698822; PMCID: PMC3766037).","journal-title":"Contraception"},{"key":"865_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12905-020-01003-8","volume":"20","author":"FA Abubeker","year":"2020","unstructured":"Abubeker FA, Lavelanet A, Rodriguez MI, Kim C. Medical termination for pregnancy in early first trimester (\u226463 days) using combination of mifepristone and misoprostol alone: a systematic review. BMC Women\u2019s Health. 2020;20:142.","journal-title":"BMC Women\u2019s Health"},{"issue":"2","key":"865_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/13625187.2011.555568","volume":"16","author":"AA Boersma","year":"2011","unstructured":"Boersma AA, Meyboom-de Jong B, Kleiverda G. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhea in a general practice in Curacao. Eur J Contracept Reprod Health Care. 2011;16(2):61\u20136.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"865_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.contraception.2004.04.009","volume":"70","author":"C Shannon","year":"2004","unstructured":"Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: a review of the literature. Contraception. 2004;70(3):183\u201390. https:\/\/doi.org\/10.1016\/j.contraception.2004.04.009. (PMID: 15325886).","journal-title":"Contraception"},{"issue":"Pt B","key":"865_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108228","volume":"101","author":"LC Abu Esba","year":"2021","unstructured":"Abu Esba LC, Al Sehli FA. Antimicrobial-associated anaphylaxis at a tertiary care medical city. Int Immunopharmacol. 2021;101(Pt B): 108228. https:\/\/doi.org\/10.1016\/j.intimp.2021.108228. (Epub 2021 Oct 14. PMID: 34655848).","journal-title":"Int Immunopharmacol."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00865-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-023-00865-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00865-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:25:33Z","timestamp":1697567133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-023-00865-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1007\/s40121-023-00865-3","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laila Abu Esba, Ghada Al Mardawi, Elham Al Mardawi, Fay Musaed Almahdi, and Husam Ardah certify that they have no conflicts of interest or competing interests to the content of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The institutional review board (IRB) at King Abdullah International Medical Research Center (KAIMRC) (Protocol RC20\/657\/R) approved this study. No consent form was required by the Ministry of National Guard Health Affairs ethics committee. This study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}